LOGC   $2.07  0.49% Market Closed

LogicBio Therapeutics Inc
Total Cash 150.00M
totalCashPerShare 5.709
EBITDA -207.00M
Total Debt 0.00
quickRatio 30.0
currentRatio 31.8
Total Revenue 156.00M
debtToEquity
Revenue/Share 6.355
ROA -0.3533
ROE -0.89612997
grossProfits
freeCashflow -421.25M
operatingCashflow -251.00M
earningsGrowth
revenueGrowth -0.91
grossMargins 0.19872
ebitdaMargins -1.32692
operatingMargins -2.71429
profitMargins -1.41026
enterpriseValue 12.64M
forwardPE
floatShares 23.63M
sharesOutstanding 26.27M
sharesShort 3.30M
sharesShortPriorMonth 3.13M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.52%
Short Ratio help_outline 11.66%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 5.875
Price To Book help_outline 1.07
earningsQuarterlyGrowth
netIncomeToCommon -220.00M
trailingEps -9.02%
forwardEps -0.04%
enterpriseToEbitda -0.06
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2024
institutionsCount 128
lastUpdated Nov. 7, 2024, 2:55 a.m.